Cite Filings / VNDA / 0001628280-26-026896

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Vanda Pharmaceuticals Inc. Filed 2026-04-23 Acc 0001628280-26-026896

Documents 1

DEFA14A Proxy Materials , defa14a-2026.htm

Around this filing

2026-04-24 4 Changes in Ownership
2026-04-24 CORRESP Correspondence Between Filers and SEC Staff
2026-04-23 ARS Annual Report to Security Holders
2026-04-23 DEFA14A Proxy Materials
2026-04-23 DEF 14A Proxy Statement
2026-04-22 8-K Executive or director change
2025-05-27 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading defa14a-2026.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…